GLOW - 70mg

GLOW is supplied as a high-purity synthetic peptide blend containing a combination of three complementary peptides - BPC-157, TB-500 and GHK-cu - presented together in a single investigational format. Each vial contains 70mg of total lyophilised material intended for laboratory and preclinical research preparation.

This peptide blend is manufactured to strict analytical standards and designed for experimental investigation in endocrine and growth-hormone related receptor models. Combining multiple peptides allows researchers to study potential synergistic interactions within GHRP and regenerative research pathways.

Peptides such as GLOW are commonly utilized in experimental settings because they can be produced in freeze-dried powder form and maintained under controlled storage conditions prior to reconstitution.

Current research data, primarily from animal and in-vitro experiments, indicates GLOW may assist laboratories examining:

• Interaction of GHRP-type peptides with ghrelin receptors
  
• Mechanisms of receptor binding at GHS-R1a
  
• Combined peptide influence on metabolic-regulation research models
  
• Short-acting growth-factor and regeneration dynamics
• Peptide concentration accuracy and stability testing

Intended Use: Product supplied strictly as an investigational research compound. It is not approved by the FDA, TGA, or any regulatory authority for therapeutic, diagnostic, or medicinal use. Not for human or animal consumption.